Charles Zhou's Stock Ratings

UBS Analyst

Charles Zhou is an analyst at UBS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/09/2025

Overall Average Return

-13.0%

Smart Score

34.3%

Overall Average Return Percentile

18th

Number of Ratings

14
Buy NowGet Alert
03/17/2025FUTUBuy Now
Futu Hldgs
$102.1833.1%
Charles Zhou34%
$130 → $136MaintainsBuyGet Alert
01/05/2024FUTUBuy Now
Futu Hldgs
$102.18-34.43%
Charles Zhou34%
→ $67UpgradeNeutral → BuyGet Alert
03/08/2023ZYMEBuy Now
Zymeworks
$11.3041.53%
Charles Zhou34%
→ $16Reiterates → BuyGet Alert
12/16/2022FUTUBuy Now
Futu Holdings
$102.18-37.37%
Charles Zhou34%
$61 → $64DowngradeOutperform → NeutralGet Alert
06/28/2022COGTBuy Now
Cogent Biosciences
$4.82211.2%
Charles Zhou34%
→ $15Initiates → BuyGet Alert
05/05/2022MGNXBuy Now
Macrogenics
$1.43
Charles Zhou34%
DowngradeBuy → NeutralGet Alert
08/02/2021PMVPBuy Now
PMV Pharma
$0.886244.17%
Charles Zhou34%
→ $56Initiates → BuyGet Alert
06/28/2021RPTXBuy Now
Repare Therapeutics
$1.403185.71%
Charles Zhou34%
→ $46Initiates → BuyGet Alert
01/22/2020QDBuy Now
Qudian
$2.95
Charles Zhou34%
DowngradeOutperform → NeutralGet Alert
11/13/2017QDBuy Now
Qudian
$2.951018.64%
Charles Zhou34%
→ $33Initiates → OutperformGet Alert
08/25/2017LFCBuy Now
China Life Insurance Co
Charles Zhou34%
UpgradeUnderperform → NeutralGet Alert
03/01/2016LFCBuy Now
China Life Insurance Co
Charles Zhou34%
DowngradeOutperform → NeutralGet Alert
08/26/2015LFCBuy Now
China Life Insurance Co
Charles Zhou34%
UpgradeNeutral → OutperformGet Alert
01/17/2013LFCBuy Now
China Life Insurance Co
Charles Zhou34%
DowngradeNeutral → UnderperformGet Alert